Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
Get Insiders for : 
Protagonist Therapeutics, Inc (PTGX)  
$25.15 0.49 (1.99%) as of 4:30 Fri 4/26


Download
   
Exchange: N/A
Security Type: N/A
Shares Out: 57,680,000
Market Cap: 1.45(B)
Last Volume: 0 Avg Vol: 0
52 Week Range: $14.05 - $32.15
Level I Sector: N/A
Level II Sector: N/A
Level III Sector: N/A

Member Indexes:
   

Rankings:
     
Insider 3 Months    :   -
Insider 6 Months    :   -
Insider 3/6 Months :   -
Guru Rank Number :  -
Guru Rank Value     :  -
Guru Occurances    :  -

 

            6 Months   1 Year   2 Year  
 
Company Profile   Protagonist Therapeutics is a clinical-stage biopharmaceutical company with various peptide-based new chemical entities in different stages of development, all derived from Co.'s proprietary technology platform. Co.'s clinical programs address two main categories of diseases; hematology and blood disorders, and inflammatory and immunomodulatory diseases. Co.'s main clinical asset, rusfertide (generic name for PTG-300) is an injectable hepcidin mimetic in development for the potential treatment of erythrocytosis, iron overload and other blood disorders. PN-943 is an investigational, orally delivered, gut-restricted alpha-4-beta-7 specific integrin antagonist for inflammatory bowel disease.

 
 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 0 0 0 0
Total Buy Value $0 $0 $0 $0
Total People Bought 0 0 0 0
Total Buy Transactions 0 0 0 0
Total Shares Sold 93,396 175,244 175,244 175,244
Total Sell Value $2,858,339 $4,519,351 $4,519,351 $4,519,351
Total People Sold 3 5 5 5
Total Sell Transactions 6 9 9 9
End Date 2024-01-28 2023-10-27 2023-04-28 2022-04-28

   
Records found: 166
  Page 1 of 7  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

  
3m +/-  
Form
   Ali Asif Chief Financial Officer   •       –      –    2024-04-18 4 S $25.11 $30,986 D/D (1,234) 37,163 2%     
   Patel Dinesh V Ph D President and CEO   •       •      –    2024-04-01 4 AS $28.31 $707,750 D/D (25,000) 549,590 -11%     
   Selick Harold E Director   –       •      –    2024-03-07 4 OE $1.89 $12,266 D/D 6,490 27,996     -
   Patel Dinesh V Ph D President and CEO   •       •      –    2024-03-01 4 AS $31.62 $948,600 D/D (30,000) 574,590 -22%     
   Ali Asif Chief Financial Officer   •       –      –    2024-03-01 4 S $32.22 $459,318 D/D (14,248) 38,397 23%     
   Ali Asif Chief Financial Officer   •       –      –    2024-03-01 4 OE $12.17 $146,040 D/D 12,000 52,645     -
   Waddill William D. Director   –       •      –    2024-03-01 4 AS $31.34 $406,637 D/D (12,975) 12,000 -22%     
   Waddill William D. Director   –       •      –    2024-03-01 4 OE $6.09 $79,018 D/D 12,975 24,975     -
   Ali Asif Chief Financial Officer   •       –      –    2024-02-29 4 S $30.61 $305,048 D/D (9,939) 40,645 19%     
   Gupta Suneel Chief Development Officer   •       –      –    2024-02-26 4 D $29.53 $126,447 D/D (4,282) 183,285     -
   Patel Dinesh V Ph D President and CEO   •       •      –    2024-02-26 4 D $29.53 $322,320 D/D (10,915) 604,590     -
   Patel Dinesh V Ph D President and CEO   •       •      –    2024-02-15 4 D $28.23 $104,931 D/D (3,717) 615,505     -
   Ali Asif Chief Financial Officer   •       –      –    2024-01-16 4 D $24.63 $35,763 D/D (1,452) 50,584     -
   Molina Arturo Md Chief Medical Officer   •       –      –    2024-01-16 4 D $24.63 $10,517 D/D (427) 48,350     -
   Gupta Suneel Chief Development Officer   •       –      –    2024-01-09 4 AS $25.00 $125,000 D/D (5,000) 187,567 -1%     
   Gupta Suneel Chief Development Officer   •       –      –    2024-01-09 4 OE $7.38 $36,900 D/D 5,000 192,567     -
   Gupta Suneel Chief Development Officer   •       –      –    2024-01-02 4 A $0.00 $0 D/D 19,250 187,567     -
   Ali Asif Chief Financial Officer   •       –      –    2024-01-02 4 A $0.00 $0 D/D 21,000 52,036     -
   Molina Arturo Md Chief Medical Officer   •       –      –    2024-01-02 4 A $0.00 $0 D/D 26,250 48,777     -
   Patel Dinesh V Ph D President and CEO   •       •      –    2024-01-02 4 A $0.00 $0 D/D 84,875 619,222     -
   Patel Dinesh V Ph D President and CEO   •       •      –    2023-12-13 4 AS $20.08 $1,506,000 D/D (75,000) 534,347 21%     
   Molina Arturo Md Chief Medical Officer   •       –      –    2023-11-15 4 S $16.24 $30,012 D/D (1,848) 22,527 -75%     
   Gupta Suneel Chief Development Officer   •       –      –    2023-10-19 4 OE $7.38 $147,600 D/D 20,000 168,317     -
   Patel Dinesh V Ph D President and CEO   •       •      –    2023-10-18 4 OE $4.21 $25,260 D/D 6,000 609,347     -
   Gupta Suneel Chief Development Officer   •       –      –    2023-05-31 4 D $26.07 $108,191 D/D (4,150) 148,037     -
  166 Records found
  1  2  3  4  5  6  7   
  Page 1 of 7
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us